申请人:Aventis Pharms S.A.
公开号:US20040053966A1
公开(公告)日:2004-03-18
The present invention relates to cancer therapy and to novel anticancer agent having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
本发明涉及癌症治疗和具有相当特定作用机制的新型抗癌剂。它还涉及新的化学化合物以及它们在人类治疗中的治疗应用。